CV1 Details

Investment Focus/Criteria

Main Focus Icon

Main Focus

In April 2018, Nordic Capital’s 2008 vintage fund, Fund VII successfully closed the transfer of its remaining nine unlisted portfolio companies including Binding Site, Sunrise Medical, Acino, Bladt Industries, Britax, Ellos Group, Itiviti, Master Marine and Sport Nordic Group to a continuation vehicle, Nordic Capital CV1. Fund VII’s original term expired in December 2017 and by this transaction, Nordic Capital will have the opportunity to maximise the value creation potential of these nine companies, providing them with active support and fresh capital over an additional five-year holding period under continued Nordic Capital management.

General Partner Board of Directors

David Hall

Ged Kelly

Jean Le Creurer

Lynda Elliott

Peter Rioda

Investors

Coller Capital acted as lead investor in the transaction, which was fully underwritten by Coller Capital and Goldman Sach Asset Management. A competitive auction process resulted in a GP-led transaction of EUR 2.5 billion in value, a reflection of the quality of the portfolio assets and confidence in Nordic Capital's ability to drive ongoing value creation for CV1.

Investors in CV1

 Chart